Global Coalition for Adaptive Research - Driving Progress for Patients – Faster. Together.Global Coalition for Adaptive ResearchGlobal Coalition for Adaptive ResearchGlobal Coalition for Adaptive Research

Driving Progress for Patients – Faster. Together.

DONATE
  • Meet GCAR
    • About Us
    • Executive Team
    • Board of Directors
    • Trials Leadership
    • Global Sites
    • Contact Us
  • Discover Our Research
    • Master Protocols & Adaptive Platform Trials
    • GBM AGILE
      • GBM AGILE | Overview
      • Leadership Council
      • Trial Sites
      • Partners
      • FAQs
    • REMAP-CAP / COVID
      • REMAP-CAP / COVID | Overview
      • US Steering Committee
      • Trial Sites
      • Partners
      • FAQs
    • OVARIAN CANCERX
      • OVARIAN CANCERX | Overview
      • Leadership
      • Partners
  • Get News + Publications
    • Scientific Presentations + Publications
    • Video Resources
    • News + Announcements
  • Make Progress
    • Support a Trial
    • Partner With Us
    • Contact Us
  • DONATE

Ovarian CanceRx

Ovarian CanceRx

Ovarian CanceRx | Overview

 

Global Coalition for Adaptive Research (GCAR) is a 501(c)3 nonprofit organization committed to developing and sponsoring Master Protocols and Adaptive Platform Trials to speed the discovery of treatments for rare and deadly diseases.
DRIVING PROGRESS FOR PATIENTS  — FASTER. TOGETHER.

 

QUICK LINKS

Meet GCAR

Discover Our Research

GBM AGILE

REMAP-CAP / COVID

Ovarian CanceRx

Get News + Publications

Make Progress

Donate

RECENT POST

  • Global Coalition for Adaptive Research Announces That Regorafenib Has Completed Follow-up in the GBM AGILE Trial for Patients With Glioblastoma September 21, 2022
  • GCAR, Biohaven, & Vigeo Announce Commencement of Biohaven’s Troriluzole & Vigeo’s VT1021 in GBM AGILE Trial July 6, 2022

 

GENERAL INQUIRIES

PARTNER INQUIRIES

 

©2023 GLOBAL COALITION FOR ADAPTIVE RESEARCH. ALL RIGHTS RESERVED.  •  PRIVACY